Principal Financial Group Inc Myriad Genetics Inc Transaction History

Principal Financial Group Inc

  • $167 Billion
  • Q1 2025

A detailed history of Principal Financial Group Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Principal Financial Group Inc holds 453,251 shares of MYGN stock, worth $1.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
453,251
Previous 441,387 2.69%
Holding current value
$1.9 Million
Previous $6.05 Million 33.56%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 28, 2025
BUY
$8.87 - $14.98 $105,233 - $177,722
11,864 Added 2.69%
453,251 $4.02 Million
Q4 2024

Jan 31, 2025
BUY
$13.17 - $27.03 $5.81 Million - $11.9 Million
441,387 New
441,387 $6.05 Million
Q3 2024

Oct 31, 2024
SELL
$23.97 - $28.6 $517,344 - $617,273
-21,583 Reduced 4.8%
428,023 $11.7 Million
Q2 2024

Jul 29, 2024
SELL
$17.98 - $25.47 $354,637 - $502,370
-19,724 Reduced 4.2%
449,606 $11 Million
Q1 2024

Apr 29, 2024
SELL
$17.59 - $23.59 $42,321 - $56,757
-2,406 Reduced 0.51%
469,330 $10 Million
Q4 2023

Feb 07, 2024
BUY
$13.91 - $21.32 $273,428 - $419,087
19,657 Added 4.35%
471,736 $9.03 Million
Q3 2023

Nov 02, 2023
SELL
$15.99 - $23.22 $347,142 - $504,106
-21,710 Reduced 4.58%
452,079 $7.25 Million
Q2 2023

Aug 07, 2023
SELL
$17.56 - $23.76 $473,979 - $641,329
-26,992 Reduced 5.39%
473,789 $11 Million
Q1 2023

May 09, 2023
SELL
$15.26 - $23.75 $92,261 - $143,592
-6,046 Reduced 1.19%
500,781 $11.6 Million
Q4 2022

Feb 09, 2023
SELL
$14.51 - $20.99 $168,374 - $243,567
-11,604 Reduced 2.24%
506,827 $7.35 Million
Q3 2022

Nov 09, 2022
SELL
$18.21 - $27.88 $383,411 - $587,013
-21,055 Reduced 3.9%
518,431 $9.89 Million
Q2 2022

Aug 10, 2022
SELL
$16.45 - $25.88 $575,947 - $906,110
-35,012 Reduced 6.09%
539,486 $9.8 Million
Q1 2022

May 09, 2022
SELL
$22.67 - $28.01 $568,495 - $702,406
-25,077 Reduced 4.18%
574,498 $14.5 Million
Q4 2021

Feb 09, 2022
SELL
$24.13 - $32.63 $1.12 Million - $1.51 Million
-46,286 Reduced 7.17%
599,575 $16.5 Million
Q3 2021

Nov 09, 2021
SELL
$29.97 - $36.66 $46,903 - $57,372
-1,565 Reduced 0.24%
645,861 $20.9 Million
Q2 2021

Aug 10, 2021
BUY
$25.39 - $32.61 $949,078 - $1.22 Million
37,380 Added 6.13%
647,426 $19.8 Million
Q1 2021

May 10, 2021
BUY
$19.92 - $31.6 $263,442 - $417,910
13,225 Added 2.22%
610,046 $18.6 Million
Q4 2020

Feb 08, 2021
SELL
$12.16 - $19.77 $761,361 - $1.24 Million
-62,612 Reduced 9.49%
596,821 $11.8 Million
Q3 2020

Nov 06, 2020
BUY
$11.25 - $14.75 $321,232 - $421,171
28,554 Added 4.53%
659,433 $8.6 Million
Q2 2020

Aug 05, 2020
BUY
$10.69 - $16.49 $468,638 - $722,905
43,839 Added 7.47%
630,879 $7.15 Million
Q1 2020

May 12, 2020
SELL
$9.78 - $29.53 $227,355 - $686,483
-23,247 Reduced 3.81%
587,040 $8.4 Million
Q4 2019

Feb 05, 2020
SELL
$20.93 - $35.1 $340,782 - $571,498
-16,282 Reduced 2.6%
610,287 $16.6 Million
Q3 2019

Nov 13, 2019
BUY
$22.08 - $47.08 $113,049 - $241,049
5,120 Added 0.82%
626,569 $17.9 Million
Q2 2019

Aug 12, 2019
SELL
$22.67 - $35.0 $122,622 - $189,315
-5,409 Reduced 0.86%
621,449 $17.3 Million
Q1 2019

May 10, 2019
SELL
$26.93 - $34.7 $486,086 - $626,335
-18,050 Reduced 2.8%
626,858 $20.8 Million
Q4 2018

Feb 14, 2019
BUY
$27.23 - $45.56 $822,808 - $1.38 Million
30,217 Added 4.92%
644,908 $18.7 Million
Q3 2018

Nov 14, 2018
BUY
$37.57 - $50.34 $1.19 Million - $1.59 Million
31,651 Added 5.43%
614,691 $28.3 Million
Q2 2018

Aug 13, 2018
SELL
$27.75 - $40.17 $18,370 - $26,592
-662 Reduced 0.11%
583,040 $0
Q1 2018

May 14, 2018
BUY
$28.83 - $41.01 $605,458 - $861,251
21,001 Added 3.73%
583,702 $17.2 Million
Q4 2017

Feb 13, 2018
BUY
$28.45 - $37.14 $1.08 Million - $1.41 Million
37,966 Added 7.24%
562,701 $19.3 Million
Q3 2017

Nov 02, 2017
BUY
$24.01 - $36.2 $12.6 Million - $19 Million
524,735
524,735 $19 Million

Others Institutions Holding MYGN

# of Institutions
240
Shares Held
95.3M
Call Options Held
95.4K
Put Options Held
18.2K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $338M
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email